GLEN ALLEN, Va.--(BUSINESS WIRE)--GENETWORx, LLC has received certification of accreditation from the College of American Pathologists (CAP) following inspection of its clinical laboratory facility in Glen Allen, VA. Utilizing the latest technology in DNA genotyping, GENETWORx offers genetic testing services and clinically referenced information which facilitate a physician’s ability to individualize treatment plans based on a patient’s DNA.
CAP accreditation is the gold standard awarded to clinical laboratories that exceed inspection qualifications. GENETWORx is now both CAP-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified for clinical sample processing of buccal swab samples for genotyping of drug-metabolizing enzymes, as well as thrombophilia risk factors. "Achieving the CAP accreditation combined with our CLIA certification demonstrates unwavering commitment to excellence at GENETWORx," says Sarah Jacobs-Helber, PhD, Laboratory Director. "Clinicians ordering our assays can have confidence that the results received are of the highest quality possible."
"Credentialing from CAP validates our vision and ensures the laboratory not only meets but exceeds government and clinical standards," says Bill Miller, CEO. GENETWORx was founded upon the principles of providing pharmacogenomic information along with medication management reports that delivers actionable information useful to the physician and, most importantly, the patient.
Our mission is to deliver meaningful Personalized Medicine results to patients, providing health care professionals the necessary tools to leverage their knowledge and truly individualize treatment plans based on a patient’s DNA – Utilizing the latest technology in DNA sequencing to help provide the right medications, at the right dose, and effectively lower overall healthcare expenditures while delivering the best health outcome for the patient.